Matches in SemOpenAlex for { <https://semopenalex.org/work/W2609920805> ?p ?o ?g. }
- W2609920805 endingPage "819" @default.
- W2609920805 startingPage "812" @default.
- W2609920805 abstract "An expanding array of options for prevention and treatment of chemotherapy-induced nausea and vomiting (CINV), including regimens containing olanzapine or recently approved neurokinin 1 (NK1) receptor antagonists, are reviewed. Up to 80% of patients receiving chemotherapy have CINV. Current practice guidelines recommend that patients treated with highly emetogenic chemotherapy also receive a 3-drug antiemetic regimen initiated on the day of and continued for 3 days after chemotherapy administration, with the most commonly used 3-drug regimen consisting of an NK1 receptor antagonist, a 5-hydroxytryptamine type 3 (5-HT3) receptor antagonist, and dexamethasone. Developments in the area of CINV management in recent years include the use of olanzapine in combination with a 5-HT3 antagonist and dexamethasone; Food and Drug Administration (FDA) approval of the NK1 receptor antagonist rolapitant, which provides a longer duration of effect than aprepitant; FDA approval of a combination product containing palonosetron and the NK1 receptor antagonist netupitant; and revisions of U.S. practice guidelines ending palonosetron’s status as the preferred 5-HT3 antagonist for prevention of CINV associated with moderately or highly emetogenic chemotherapy. Newer therapeutic options for the management of CINV are equivalent to standard-of-care regimens in terms of efficacy and toxicity. While the NK1 receptor antagonist rolapitant and a product combining palonosetron and netupitant have potential advantages over standard therapy in terms of convenience or pharmacologic properties, their relatively high costs must be considered." @default.
- W2609920805 created "2017-05-05" @default.
- W2609920805 creator A5016348831 @default.
- W2609920805 creator A5018136342 @default.
- W2609920805 date "2017-06-01" @default.
- W2609920805 modified "2023-10-18" @default.
- W2609920805 title "New options and controversies in the management of chemotherapy-induced nausea and vomiting" @default.
- W2609920805 cites W1817463461 @default.
- W2609920805 cites W1876492466 @default.
- W2609920805 cites W1950224348 @default.
- W2609920805 cites W1994776603 @default.
- W2609920805 cites W2029309368 @default.
- W2609920805 cites W2035395673 @default.
- W2609920805 cites W2054647499 @default.
- W2609920805 cites W2055125378 @default.
- W2609920805 cites W2065765429 @default.
- W2609920805 cites W2066209834 @default.
- W2609920805 cites W2067976131 @default.
- W2609920805 cites W2087575003 @default.
- W2609920805 cites W2105467170 @default.
- W2609920805 cites W2107985230 @default.
- W2609920805 cites W2108765055 @default.
- W2609920805 cites W2116571828 @default.
- W2609920805 cites W2120970263 @default.
- W2609920805 cites W2128040637 @default.
- W2609920805 cites W2143288648 @default.
- W2609920805 cites W2152250751 @default.
- W2609920805 cites W2155440673 @default.
- W2609920805 cites W2156319350 @default.
- W2609920805 cites W2162984217 @default.
- W2609920805 cites W2164832682 @default.
- W2609920805 cites W2165395427 @default.
- W2609920805 cites W2236401105 @default.
- W2609920805 cites W2316015629 @default.
- W2609920805 cites W2324983656 @default.
- W2609920805 cites W2325575764 @default.
- W2609920805 cites W4246705037 @default.
- W2609920805 cites W4322702215 @default.
- W2609920805 doi "https://doi.org/10.2146/ajhp160227" @default.
- W2609920805 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28396308" @default.
- W2609920805 hasPublicationYear "2017" @default.
- W2609920805 type Work @default.
- W2609920805 sameAs 2609920805 @default.
- W2609920805 citedByCount "9" @default.
- W2609920805 countsByYear W26099208052017 @default.
- W2609920805 countsByYear W26099208052018 @default.
- W2609920805 countsByYear W26099208052019 @default.
- W2609920805 countsByYear W26099208052020 @default.
- W2609920805 countsByYear W26099208052021 @default.
- W2609920805 countsByYear W26099208052022 @default.
- W2609920805 countsByYear W26099208052023 @default.
- W2609920805 crossrefType "journal-article" @default.
- W2609920805 hasAuthorship W2609920805A5016348831 @default.
- W2609920805 hasAuthorship W2609920805A5018136342 @default.
- W2609920805 hasBestOaLocation W26099208051 @default.
- W2609920805 hasConcept C118303440 @default.
- W2609920805 hasConcept C126322002 @default.
- W2609920805 hasConcept C143998085 @default.
- W2609920805 hasConcept C170493617 @default.
- W2609920805 hasConcept C202871150 @default.
- W2609920805 hasConcept C2776533618 @default.
- W2609920805 hasConcept C2776712918 @default.
- W2609920805 hasConcept C2779924295 @default.
- W2609920805 hasConcept C2780574406 @default.
- W2609920805 hasConcept C2780580376 @default.
- W2609920805 hasConcept C2780852908 @default.
- W2609920805 hasConcept C2780884295 @default.
- W2609920805 hasConcept C2781413609 @default.
- W2609920805 hasConcept C71924100 @default.
- W2609920805 hasConcept C98274493 @default.
- W2609920805 hasConceptScore W2609920805C118303440 @default.
- W2609920805 hasConceptScore W2609920805C126322002 @default.
- W2609920805 hasConceptScore W2609920805C143998085 @default.
- W2609920805 hasConceptScore W2609920805C170493617 @default.
- W2609920805 hasConceptScore W2609920805C202871150 @default.
- W2609920805 hasConceptScore W2609920805C2776533618 @default.
- W2609920805 hasConceptScore W2609920805C2776712918 @default.
- W2609920805 hasConceptScore W2609920805C2779924295 @default.
- W2609920805 hasConceptScore W2609920805C2780574406 @default.
- W2609920805 hasConceptScore W2609920805C2780580376 @default.
- W2609920805 hasConceptScore W2609920805C2780852908 @default.
- W2609920805 hasConceptScore W2609920805C2780884295 @default.
- W2609920805 hasConceptScore W2609920805C2781413609 @default.
- W2609920805 hasConceptScore W2609920805C71924100 @default.
- W2609920805 hasConceptScore W2609920805C98274493 @default.
- W2609920805 hasIssue "11" @default.
- W2609920805 hasLocation W26099208051 @default.
- W2609920805 hasLocation W26099208052 @default.
- W2609920805 hasOpenAccess W2609920805 @default.
- W2609920805 hasPrimaryLocation W26099208051 @default.
- W2609920805 hasRelatedWork W100286279 @default.
- W2609920805 hasRelatedWork W1480067006 @default.
- W2609920805 hasRelatedWork W1747184343 @default.
- W2609920805 hasRelatedWork W2052445101 @default.
- W2609920805 hasRelatedWork W2057039455 @default.
- W2609920805 hasRelatedWork W22360130 @default.
- W2609920805 hasRelatedWork W2429814034 @default.
- W2609920805 hasRelatedWork W2806893525 @default.